Cumulative PPI Use for More Than 4.4 Years Linked to Increased Risk for Dementia
THURSDAY, Aug. 10, 2023 (HealthDay News) — Cumulative use of proton pump inhibitors (PPIs) for more than 4.4 years is associated with an increased risk for dementia, according to a study published online Aug. 9 in Neurology.Carin Northuis, M.P.H., Ph…
Learn MoreCould Popular Heartburn Meds Raise Your Odds for Dementia?
THURSDAY, Aug. 10, 2023 (HealthDay News) — Older adults who use certain heartburn medications for years may have a heightened risk of developing dementia, a new study suggests.The study, published Aug. 9 in the journal Neurology, is the latest to poi…
Learn MoreGI Symptoms Persist in Most Female Colorectal Cancer Survivors
WEDNESDAY, Aug. 9, 2023 (HealthDay News) — Female colorectal cancer (CRC) survivors experience a high burden of gastrointestinal (GI) symptoms, according to a study recently published in PLOS ONE.Claire J. Han, from The Ohio State University in Colum…
Learn MoreLos problemas gastrointestinales pueden persistir durante años en las mujeres tras un cáncer de colon
LUNES, 7 de agosto de 2023 (HealthDay News) — Los sobrevivientes a un cáncer de colon están viviendo más tiempo que nunca, pero la inmensa mayoría de las mujeres tratadas por la enfermedad tienen unos síntomas gastrointestinales (GI) persistentes, po…
Learn MoreGI Troubles Can Persist for Years in Women Who Survive Colon Cancer
MONDAY, Aug. 7, 2023 (HealthDay News) — Colon cancer survivors are living longer than ever, but the vast majority of women treated for the disease have lingering gastrointestinal symptoms, such as bloating and gas, new research reveals. Roughly eight…
Learn MoreUna demanda contra los fabricantes de Ozempic y Mounjaro sostiene que provocaron una ‘parálisis estomacal’
JUEVES, 3 de agosto de 2023 (HealthDay News) — Una mujer de Luisiana está demandando a los fabricantes de dos medicamentos para la diabetes tipo 2 que se usan fuera de etiqueta para la obesidad, y afirma que no advirtieron de forma adecuada sobre el …
Learn MoreLawsuit Against Makers of Ozempic, Mounjaro Claim Meds Caused ‘Stomach Paralysis’
THURSDAY, Aug. 3, 2023 (HealthDay News) — A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk for severe stomach problems.The lawsuit seeks “very signific…
Learn MoreLower Fiber Intake Tied to Higher Risk for Later Inflammatory Bowel Disease
THURSDAY, Aug. 3, 2023 (HealthDay News) — Higher consumption of dietary fiber was associated with a lower risk for inflammatory bowel disease (IBD), according to a study published online July 18 in Alimentary Pharmacology and Therapeutics.Minzi Deng,…
Learn MoreLawsuit Against Makers of Ozempic, Mounjaro Claim Meds Caused ‘Stomach Paralysis’
THURSDAY, Aug. 3, 2023 (HealthDay News) — A Louisiana woman is suing the makers of two type 2 diabetes drugs used off-label for obesity, saying they failed to adequately warn about the risk of severe stomach problems.The lawsuit seeks “very significa…
Learn More